Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units
Genome Med. 2021 Nov 17;13(1):182. doi: 10.1186/s13073-021-00991-y. ABSTRACT BACKGROUND: Clinical metagenomics (CMg) has the potential to be translated from a research tool into routine service
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
bioRxiv. 2021 Mar 10:2021.03.10.434840. doi: 10.1101/2021.03.10.434840. Preprint. ABSTRACT Memory B cell reserves can generate protective antibodies against repeated SARS-CoV-2 infections, but with an unknown reach
Mast Cells in Lung Damage of COVID-19 Autopsies: a descriptive study
Allergy. 2022 Mar 27. doi: 10.1111/all.15293. Online ahead of print. NO ABSTRACT PMID:35340030 | DOI:10.1111/all.15293
Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema
Clin Exp Allergy. 2022 Mar 12. doi: 10.1111/cea.14122. Online ahead of print. ABSTRACT BACKGROUND: Hereditary angioedema (HAE) is a rare genetic disease that leads to
SARS-CoV-2-specific ELISA development
J Immunol Methods. 2020 Sep-Oct;484-485:112832. doi: 10.1016/j.jim.2020.112832. Epub 2020 Aug 8. ABSTRACT Critical to managing the spread of COVID-19 is the ability to diagnose infection
Antibodies induced by ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1
Sci Immunol. 2022 May 10:eabo3425. doi: 10.1126/sciimmunol.abo3425. Online ahead of print. ABSTRACT Neutralizing antibodies that recognize the SARS-CoV-2 spike glycoprotein are the principal host defense